Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Hisse Senetlerindeki Sıralama #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Hisse Fiyatı
$154.51
Piyasa Değeri
$55.98B
Değişim (1 gün)
-1.82%
Değişim (1 yıl)
-32.08%
Ülke
US
Ticaret Becton, Dickinson and Company (BDX)

Kategori

Becton, Dickinson and Company (BDX) için Faaliyet Marjı
March 2026 itibarıyla Faaliyet Marjı TTM: 12.40%
Becton, Dickinson and Company şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 12.40%'dir. 2024 yılı sonunda şirketin faaliyet marjı 11.88% idi.
Becton, Dickinson and Company için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
Yıl Faaliyet Marjı Değiştir
2026 (TTM) 12.40% 5.08%
2025 11.80% -0.67%
2024 11.88% 8.99%
2023 10.90% -9.84%
2022 12.09% 2.81%
2021 11.76% 107.41%
2020 5.67% -44.30%
2019 10.18% 7.84%
2018 9.44% -25.02%
2017 12.59% 9.86%
2016 11.46% 9.67%
2015 10.45% -45.03%
2014 19.01% 22.09%
2013 15.57% -22.96%
2012 20.21% -8.01%
2011 21.97% -1.08%
2010 22.21% -2.37%
2009 22.75% 4.74%
2008 21.72% 14.80%
2007 18.92% -4.88%
2006 19.89% 4.52%
2005 19.03% 19.31%
2004 15.95% -6.45%
2003 17.05% 0.12%
2002 17.03% -0.99%
2001 17.20% 8.72%
2000 15.82% 0.00%
Benzer şirketler veya rakipler için Faaliyet Marjı
Şirket Faaliyet Marjı Faaliyet Marjı Farkı Ülke
29.27% -97.64%
US
16.22% -98.69%
DE
29.61% -97.61%
JP
13.08% -98.95%
CH
33.81% -97.27%
US
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.